News | December 27, 2025
Symbiosis rolls out first 10,000 vial batch at Stirling Facility
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
The expansion includes a larger technical and service team and increased local procurement
The EIR was issued following an inspection of the facility from September 8 to September 16, 2025
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The inspection concluded with one minor observation in Form 483
This approval confirms the facility's compliance with FDA quality standards and regulatory requirements
The new site marks the company’s first operation in the region
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Subscribe To Our Newsletter & Stay Updated
